Medical specialists from Sweden tagged as investigators in clinical trials studying Mantle Cell Lymphoma
Total 26 results
-
Anna Laurell, Dr.Seen in:
- Uppsala, Academic Hospital, Dept of Oncology
Trials:- NCT02858258 (Principal Investigator)
Conditions: -
Catharina LewerinSeen in:
- Göteborg, Sahlgrenska University Hospital, Section of Hematology and Coagulation, Dept of internal medicine
Trials:- NCT02858258 (Principal Investigator)
Conditions: -
David LöfgrenSeen in:
- Örebro, Örebro University Hospital, Dept of Oncology
Trials:- NCT02858258 (Sub-Investigator)
Conditions: -
Fredrik Celsing, Dr.Seen in:
- Stockholm, Karolinska University Hospital, Center of Hematology
Trials:- NCT02858258 (Sub-Investigator)
Conditions: -
Fredrik EllinSeen in:
- Kalmar, Department of Internal Medicine, Kalmar County Hospital
Trials:- NCT04332822 (Principal Investigator)
- NCT05214183 (Principal Investigator)
Conditions: -
Ingemar LagerlöfSeen in:
- Linköping, Hematologiska Kliniken, Universitetssjukhuset
- Linköping, University Hospital, Dept of Hematolgy
Trials:- NCT04332822 (Principal Investigator)
- NCT05214183 (Principal Investigator)
- NCT02858258 (Principal Investigator)
Conditions: -
Ingrid GlimeliusSeen in:
- Uppsala, Academic Hospital, Dept of Oncology
- Uppsala, Department of Oncology, Uppsala Academic Hospital
Trials:- NCT05214183 (Principal Investigator)
- NCT02858258 (Sub-Investigator)
Conditions: -
Karin Nyström, Dr.Seen in:
- Örebro, Örebro University Hospital, Dept of Oncology
Trials:- NCT02858258 (Principal Investigator)
Conditions: -
Karin PapworthSeen in:
- Umea, Norrland University Hospital, Dept of Oncology
- Umeå, Cancercentrum, Norrlands universitetsjukhus
Trials:- NCT02858258 (Principal Investigator)
- NCT05214183 (Principal Investigator)
Conditions: -
Kristina SonneviSeen in:
- Stockholm, Center of Hematology, Karolinska University Hospital
- Stockholm, Karolinska University Hospital, Center of Hematology
Trials:- NCT05214183 (Principal Investigator)
- NCT02858258 (Principal Investigator)
Conditions: -
Lena BrandeforsSeen in:
- Lulea, Sunderbyn Hospital, Dept of Medicine
- Luleå, Department of Medicine, Sunderbyn Hospital
- Södra Sunderbyn, Department of Medicine, Sunderbyn Hospital
Trials:- NCT04332822 (Principal Investigator)
- NCT05214183 (Principal Investigator)
- NCT02858258 (Principal Investigator)
Conditions: -
Lina WideSeen in:
- Uddevalla, Uddevalla Hospital
- Uddevalla, Uddevalla Sjukhus
Trials:- NCT04332822 (Principal Investigator)
- NCT05214183 (Principal Investigator)
Conditions: -
Maria Ljungqvist, Dr.Seen in:
- Stockholm, Karolinska University Hospital, Center of Hematology
Trials:- NCT02858258 (Sub-Investigator)
Conditions: -
Martin StensonSeen in:
- Göteborg, Department of Hematology and Coagulation, Sahlgrenska University Hospital
Trials:- NCT05214183 (Principal Investigator)
Conditions: -
Mats JerkemanSeen in:
- Lund, Department of Oncology, Skåne University Hospital
- Lund, Mats Jerkeman
- Lund, Skane University Hospital
Trials:- NCT04332822 (Principal Investigator)
- NCT05214183 (Principal Investigator)
- NCT02858258 (Principal Investigator)
Conditions: -
Max FlogegårdSeen in:
- Falun, GSK Investigational Site
- Falun, Hematological Department, Falu Hospital, Falun
Trials:- NCT04126200 (Principal Investigator)
- NCT05214183 (Principal Investigator)
Conditions: -
Nevzeta KuricSeen in:
- Halmstad, Department of Medicine, Halmstad Country Hospital
Trials:- NCT04332822 (Principal Investigator)
- NCT05214183 (Principal Investigator)
Conditions: -
Ronald Svensson, Dr.Seen in:
- Linköping, University Hospital, Dept of Hematolgy
Trials:- NCT02858258 (Sub-Investigator)
Conditions: -
Sara Sjöström, Dr.Seen in:
- Umea, Norrland University Hospital, Dept of Oncology
Trials:- NCT02858258 (Sub-Investigator)
Conditions: -
Torsten Dahlen, Dr.Seen in:
- Stockholm, Karolinska University Hospital, Center of Hematology
Trials:- NCT02858258 (Sub-Investigator)
Conditions: -
Urban JerlströmSeen in:
- Örebro, Örebro University Hospital, Dept of Oncology
Trials:- NCT02858258 (Sub-Investigator)
Conditions:
Clinical Trials on Mantle Cell Lymphoma
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCActive, not recruitingStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkCompletedStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Stage I Mantle Cell Lymphoma | Stage II Contiguous Mantle Cell Lymphoma | Stage II Non-Contiguous Mantle Cell LymphomaUnited States
-
Burzynski Research InstituteWithdrawnRecurrent Mantle Cell Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell LymphomaUnited States
-
University of WashingtonNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Ann Arbor Stage I Mantle Cell Lymphoma | Ann Arbor Stage II Mantle Cell Lymphoma | Ann Arbor Stage III Mantle Cell Lymphoma | Ann Arbor Stage IV Mantle Cell LymphomaUnited States
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, China, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina, Puerto Rico
-
BeiGeneCompletedRefractory Mantle Cell Lymphoma | Relapsed Mantle Cell LymphomaChina
-
Fondazione Italiana Linfomi - ETSRecruitingRefractory Mantle Cell Lymphoma | Relapsed Mantle Cell LymphomaItaly
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Central Nervous System Lymphoma | Gastric Mantle Cell Lymphoma | Splenic Mantle Cell LymphomaUnited States